Type
. Evaluation of drug regimen in lepromatous leprosy--II. Leprosy in India. 1983;55(2):200-8.
Type
. Care of hand and feet in leprosy. The Nursing journal of India. 1983;74(4):93.
Type
. Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1983;51(1):33-40.
Type
. A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to the MY2a determinant of Mycobacterium leprae. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1983;77(6):869-71.
Type
. The chemotherapy of leprosy. Progress in medicinal chemistry. 1983;20:1-81.
Type
. Suppressor cells of mouse and man. What is the evidence that they contribute to the aetiology of the mycobacterioses?. Leprosy review [Internet]. 1982;53(4):306-12. Available from: http://leprev.ilsl.br/pdfs/1982/v53n4/pdf/v53n4a10.pdf
Type
. T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors. Immunology. 1982;47(4):589-95.
Type
. Treatment of sulphone resistant leprosy--a review of sixty one cases. Leprosy in India. 1982;54(4):639-47.
Type
. Composite skin contact smears in multibacillary leprosy patients. Leprosy in India. 1982;54(4):605-12.
Type
. SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos. Clinical and experimental immunology. 1982;49(3):523-31.